Jiangsu Hengrui Medicine Co., Ltd.
600276
Classement en actions
#544
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Prix de l'action
$6.89
Capitalisation boursière
$43.94B
Changement (1 jour)
-2.91%
Changement (1 an)
-24.78%
Pays
CN
Échange Jiangsu Hengrui Medicine Co., Ltd. (600276)
Catégorie
Healthcare
Nombre d'actions en circulation pour Jiangsu Hengrui Medicine Co., Ltd. (600276)
Nombre d'actions en circulation au October 2026: 0
Selon les derniers rapports financiers et le cours de l'action de Jiangsu Hengrui Medicine Co., Ltd., le nombre actuel d'actions en circulation est de 0. À la fin de October 2026, l'entreprise avait 0 actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Jiangsu Hengrui Medicine Co., Ltd. (600276) de 2001 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2025 | 6.50B | 2.58% |
| 2024 | 6.34B | 0.15% |
| 2023 | 6.33B | -0.63% |
| 2022 | 6.37B | -0.21% |
| 2021 | 6.38B | 0.38% |
| 2020 | 6.36B | 0.31% |
| 2019 | 6.34B | -0.42% |
| 2018 | 6.36B | 1.14% |
| 2017 | 6.29B | -0.45% |
| 2016 | 6.32B | -0.18% |
| 2015 | 6.33B | 0.46% |
| 2014 | 6.30B | -0.11% |
| 2013 | 6.31B | 0.29% |
| 2012 | 6.29B | -0.01% |
| 2011 | 6.29B | 0.36% |
| 2010 | 6.27B | 0.00% |
| 2009 | 6.27B | 0.26% |
| 2008 | 6.25B | -0.01% |
| 2007 | 6.25B | 0.00% |
| 2006 | 6.25B | 87.25% |
| 2005 | 3.34B | 0.00% |
| 2004 | 3.34B | 0.00% |
| 2003 | 3.34B | 0.00% |
| 2002 | 3.34B | 0.00% |
| 2001 | 3.34B | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
